-
D. Boral Capital Downgrades Enlivex Therapeutics (ENLV) to Hold
-
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
H.C. Wainwright Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
-
Enlivex CEO outlines roadmap after knee arthritis trial results
-
Enlivex reports positive knee osteoarthritis trial results for Allocetra
-
Enlivex Therapeutics and Foremost Clean Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
H.C. Wainwright Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
-
Enlivex Therapeutics (ENLV) PT Raised to $7 at H.C. Wainwright
-
Enlivex (ENLV) Announces Positive Interim Data – Statistically Significant 47.0% Durable and Persistent Pain Reduction At Six Months, in Patients with Moderate to Severe Knee Osteoarthritis
-
Enlivex (ENLV) Issues Urgent Statement on Fraudulent News Dissemination
-
RedChip Announces Webinar to Teach Investors How to Use RedChat, a Revolutionary AI Chatbot for Small-Cap Stock Analysis
-
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3
-
H.C. Wainwright Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
-
EF Hutton Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
-
H.C. Wainwright Reiterates Buy Rating on Enlivex Therapeutics (ENLV)
-
GreenPower and Enlivex Interviews to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV
-
EF Hutton Starts Enlivex Therapeutics (ENLV) at Buy
-
Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Enlivex Therapeutics (ENLV) PT Lowered to $6 at H.C. Wainwright

